Sign in

CIK 0002020932 · Non-accelerated filer<br>Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
other
Phone
32 3 302 35 30
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
Open-market buys, last 90 days
$503,470
in 6 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$503,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Epstein David R +$323K Director 4 filings
  2. Knotnerus Tim Jasper +$94K Chief Executive Officer 1 filing
  3. Kemula Pierre Thadee Victor +$86K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
No insider trades stored.